menu
    • menu

    Company profile for Torii Pharmaceutical

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Torii Pharmaceutical Co., Ltd. aims to contribute to the improvement of human health and to fulfill its responsibilities to customers, shareholders, society and employees, by supplying world-class pharmaceutical products.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Torii Pharmaceuticaljapan Flag
    Country
    Country
    Japan
    Address
    Address
    3-4-1 Nihombashihoncho Chuo-Ku, 103-8439
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.torii.co.jp/en/company/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/t
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Verrica Partner Torii Gets Approval for YCANTH (TO-208) in Japan
    Verrica Partner Torii Gets Approval for YCANTH (TO-208) in Japan

    19 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/19/3153129/0/en/Verrica-Pharmaceuticals-Announces-That-Development-Partner-Torii-Pharmaceutical-Receives-Approval-for-YCANTH-TO-208-in-Japan-for-the-Treatment-of-Molluscum-Contagiosum.html

    GLOBENEWSWIRE
    19 Sep 2025
    Share Share
    Verrica, Torii Pharma to Launch Ph3 Trial for YCANTH® in Warts
    Verrica, Torii Pharma to Launch Ph3 Trial for YCANTH® in Warts

    01 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/01/3108201/0/en/Verrica-Pharmaceuticals-Announces-Amendment-to-Collaboration-and-License-Agreement-with-Torii-Pharmaceutical-to-Launch-Global-Pivotal-Phase-3-Clinical-Trial-to-Study-YCANTH-for-the.html

    GLOBENEWSWIRE
    01 Jul 2025
    Share Share
    Shionogi to buy Japan Tobacco's unit Torii Pharmaceutical for $1 B
    Shionogi to buy Japan Tobacco's unit Torii Pharmaceutical for $1 B

    08 May 2025

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/japans-shionogi-buy-torii-pharmaceutical-1-billion-nikkei-says-2025-05-07/

    REUTERS
    08 May 2025
    Share Share
    Verrica Announces Torii Amendment To Fund YCANTH Warts Phase 3 Trial
    Verrica Announces Torii Amendment To Fund YCANTH Warts Phase 3 Trial

    15 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/15/2882311/0/en/Verrica-Pharmaceuticals-Announces-Amendment-to-Company-s-Collaboration-and-License-Agreement-with-Torii-Pharmaceutical-Co-Ltd-to-Fund-Global-Pivotal-Phase-3-Clinical-Trial-to-Study.html

    GLOBENEWSWIRE
    15 May 2024
    Share Share
    Torii Announces Positive Results from a Confirmatory Phase 3 Trial of TO-208
    Torii Announces Positive Results from a Confirmatory Phase 3 Trial of TO-208

    15 Dec 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/12/15/2796913/0/en/Verrica-Pharmaceuticals-Development-and-Commercialization-Partner-Torii-Pharmaceutical-Co-Ltd-Announces-Positive-Top-line-Results-from-a-Confirmatory-Phase-3-Trial-of-TO-208-for-th.html

    GLOBENEWSWIRE
    15 Dec 2023
    Share Share
    Verrica Pharma Starts PIII Trial of VP-102 for Molluscum Contagiosum
    Verrica Pharma Starts PIII Trial of VP-102 for Molluscum Contagiosum

    01 Aug 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/08/01/2489298/0/en/Verrica-Pharmaceuticals-Announces-Start-of-Phase-3-Trial-of-VP-102-for-the-Treatment-of-Molluscum-Contagiosum-by-Torii-Pharmaceutical-Co-Ltd-in-Japan.html

    GLOBENEWSWIRE
    01 Aug 2022
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search